Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Invasive Fungal Infections Market Growth Evolved From 2024 To 2025, And What’s Ahead?
The market size for invasive fungal infections has been experiencing continuous growth in recent years. The value is estimated to escalate from $7.58 billion in 2024 to $7.91 billion in 2025, rising at a compound annual growth rate (CAGR) of 4.3%. The earlier stage growth can be linked to worldwide spread of infections, transplants of hematopoietic stem cells, growth in the older population, infections acquired in hospitals, and environmental elements.
The invasive fungal infections market size is expected to see steady growth in the next few years. It will grow to $9.5 billion in 2029 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to global health preparedness, public health education, novel antifungal agents, climate change impact, multidisciplinary approaches. Major trends in the forecast period include advancements in diagnostic technologies, tailored therapeutic approaches, patient-centric care, combination antifungal therapies, collaborations for drug development.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13189&type=smp
What Are the Core Growth Drivers Propelling the Invasive Fungal Infections Market Forward?
The invasive fungal infection market is predicted to be driven by the increased prevalence of human immunodeficiency virus (HIV). HIV impairs the capability of the immune system to fight off diseases, hence, the increase in individuals with compromised immunity due to HIV or AIDS (acquired immunodeficiency syndrome) enhances the risk of invasive fungal infections. This provides an opportunity for drug manufacturers to introduce and distribute more potent antifungal treatments. For instance, The Joint United Nations Programme on HIV/AIDS (UNAIDS), a program of the United Nations headquartered in Switzerland that focuses on the worldwide HIV/AIDS epidemic, reported that the global count of those living with HIV rose to 39 million in 2022, which is an increase of 3.17% from 37.7 million in 2020. Additionally, around 1.3 million new HIV infections were documented in 2022. Consequently, the increasing cases of the human immunodeficiency virus (HIV) are anticipated to fuel the growth of the invasive fungal infection market.
What Segment Types Define the Invasive Fungal Infections Market Structure?
The invasive fungal infectionsmarket covered in this report is segmented –
1) By Disease Type: Candidemia And Invasive Candidiasis; Intra Abdominal Candidiasis; Cryptococcal Meningitis; Esophageal Candidiasis; Histoplasmosis Acute Pulmonary; Other Disease Type
2) By Drug Type: Polyenes; Triazoles; Echinocandins; Flucytosine; Other Drug Type
3) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
Subsegments:
1) By Candidemia And Invasive Candidiasis: Bloodstream Infections; Disseminated Candidiasis
2) By Intra-Abdominal Candidiasis: Peritoneal Candidiasis; Abscess Formation
3) By Cryptococcal Meningitis: Primary Cryptococcal Meningitis; Secondary Cryptococcal Meningitis
4) By Esophageal Candidiasis: Acute Esophageal Candidiasis; Chronic Esophageal Candidiasis
5) By Histoplasmosis Acute Pulmonary: Disseminated Histoplasmosis; Chronic Pulmonary Histoplasmosis
6) By Other Disease Types: Aspergillosis; Mucormycosis; Other Rare Fungal Infections
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13189&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Invasive Fungal Infections Market?
North America was the largest region in the invasive fungal infections market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the invasive fungal infections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which Emerging Trends that Are Influencing theInvasive Fungal Infections Industry Evolution?
Major corporations active in the invasive fungal infection market, are concentrating on the innovation of products such as Zisavel capsules to boost treatment efficiency, improve patient results, and provide better access to those suffering from severe fungal infections. Zisavel capsules are a standard antifungal drug developed from isavuconazole and are intended for invasive aspergillosis and mucormycosis treatment. These 100 mg capsules are designed to offer a cost-effective solution for patients, improving access to efficient treatment. For example, in October 2023, BDR Pharmaceuticals, a generic and specialty pharmaceutical company based in India, introduced Zisavel Capsules, a generic antifungal drug for treating invasive aspergillosis and mucormycosis. Zisavel is specified for the treatment of invasive aspergillosis and mucormycosis, both of which are high-risk fungal infections. The launch of Zisavel is aimed at making the treatment more affordable to patients by reducing prices substantially compared to existing alternatives such as voriconazole and posaconazole.
View the full report here:
https://www.thebusinessresearchcompany.com/report/invasive-fungal-infections-global-market-report
What Is the Definition of the Invasive Fungal Infections Market?
Invasive fungal infections refer to severe diseases caused by pathogenic fungi that penetrate and spread within the body beyond the point of initial infection. These infections are characterized by the penetration of fungal organisms into deeper layers of tissue, such as the bloodstream, organs, or other body structures. Invasive fungal infection treatment typically includes using antifungal medications and surgical procedures to excise infected tissue in certain instances.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13189
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model